- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Patent holdings for IPC class A61K 47/65
Total number of patents in this class: 1686
10-year publication summary
|
34
|
53
|
102
|
187
|
180
|
174
|
179
|
194
|
230
|
113
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19989 |
28 |
| SeaGen Inc | 589 |
26 |
| Daiichi Sankyo Company, Limited | 1878 |
25 |
| Bayer Pharma AG | 1052 |
20 |
| Genequantum Healthcare (Suzhou) Co., Ltd. | 63 |
18 |
| Bicyclerd Limited | 145 |
17 |
| SynDevRx, Inc. | 46 |
16 |
| CytomX Therapeutics, Inc. | 222 |
15 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 643 |
15 |
| Genentech, Inc. | 3978 |
14 |
| Cornell University | 3314 |
14 |
| MedImmune Limited | 617 |
14 |
| Bristol-myers Squibb Company | 4881 |
12 |
| ImmunoGen, Inc. | 399 |
12 |
| The Johns Hopkins University | 5679 |
11 |
| Regeneron Pharmaceuticals, Inc. | 4296 |
11 |
| Hoffmann-La Roche Inc. | 3447 |
10 |
| Duke University | 3072 |
10 |
| Purdue Research Foundation | 3638 |
10 |
| Blaze BioScience, Inc. | 76 |
10 |
| Other owners | 1378 |